TABLE 2.
Radiopharmaceutical | Target | Treatment conditions |
---|---|---|
177Lu-DOTA.SA.FAPi | FAP | Solid tumors |
177Lu-DOTAGA.(SA.FAPi)2 | FAP | Solid tumors |
177Lu-FAPi-46 | FAP | Solid tumors |
177Lu-trastuzumab | HER2 | Breast Cancer |
177Lu-brentuximab | CAIX | Hypoxic tumors |
177Lu-PP-F11N | CCK2R | Medullary Thyroid Cancer |